Premium
Cerebroretinal microangiopathy with calcifications and cysts (CRMCC)
Author(s) -
Briggs T.A.,
AbdelSalam G.M.H.,
Balicki M.,
Baxter P.,
Bertini E.,
Bishop N.,
Browne B.H.,
Chitayat D.,
Chong W.K.,
Eid M.M.,
Halliday W.,
Hughes I.,
KlusmannKoy A.,
Kurian M.,
Nischal K.K.,
Rice G.I.,
Stephenson J.B.P.,
Surtees R.,
Talbot J.F.,
Tehrani N.N.,
Tolmie J.L.,
Toomes C.,
van der Knaap M.S.,
Crow Y.J.
Publication year - 2007
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.32080
Subject(s) - microangiopathy , calcification , pathology , leukoencephalopathy , pathogenesis , medicine , coats' disease , calcinosis , retinal , ophthalmology , disease , diabetes mellitus , endocrinology
Abstract Extensive intracranial calcifications and leukoencephalopathy are seen in both Coats plus and leukoencephalopathy with calcifications and cysts (LCC; Labrune syndrome). Coats plus syndrome is additionally characterized by the presence of bilateral retinal telangiectasia and exudates while LCC shows the progressive formation of parenchymal brain cysts. Despite these apparently distinguishing features, recent evidence suggests that Coats plus and LCC represent the same clinical entity with a common primary pathogenesis involving a small vessel obliterative microangiopathy. Here, we describe eight previously unreported cases, and present an update on one of the original Coats plus patients to highlight the emerging core clinical features of the “cerebroretinal microangiopathy with calcification and cysts” (CRMCC) phenotype. © 2007 Wiley‐Liss, Inc.